A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas

Agulnik, M. ; Costa, R.L.B. ; Milhem, M. ; Rademaker, A.W. ; Prunder, B.C. ; Daniels, D. ; Rhodes, B.T. ; Humphreys, C. ; Abbinanti, S. ; Nye, L. ; Cehic, R. ; Polish, A. ; Vintilescu, C. ; McFarland, T. ; Skubitz, K. ; Robinson, S. ; Okuno, S. ; Van Tine, B.A.

England: Elsevier Ltd

Texto completo disponível

LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial

Ahn, M-J. ; Kim, S-W. ; Costa, E. Carcereny ; Rodríguez, L.M. ; Oliveira, J. ; Insa Molla, M.A. ; Majem, M. ; Costa, L. ; Su, W-C. ; Lee, K.H. ; Yang, J.C-H. ; Spigel, D.R. ; Cho, E.K. ; D'Arcangelo, M. ; Campelo, M.R. Garcia ; Delmonte, A. ; Mitchell, P. ; Achour, I. ; Subramaniam, D. ; Felip, E.

Texto completo disponível

P-171 Prognostic value of conversion from RAS-mutated to RAS wild-type during treatment of metastatic colorectal cancer using liquid biopsies – real-world data of two Portuguese institutions

Albuquerque, J. ; Neto da Silva, D. ; Padrão, T. ; Leal da Costa, L. ; Bizarro, R. ; Correia, J. ; Baptista, C. ; Machete, M. ; Prazeres, G. ; Margarido, I. ; Fernandes, G. ; Simões, P. ; Timóteo, T. ; Lopes, F. ; Godinho, J. ; Moreira-Pinto, J. ; Rodrigues, T. ; Faria, A. ; Pulido, C. ; Cirnes, L. ; Teixeira, J. ; Passos-Coelho, J.

Texto completo disponível

Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis

Ali, S. M. ; Demers, L. M. ; Leitzel, K. ; Harvey, H. A. ; Clemens, D. ; Mallinak, N. ; Engle, L. ; Chinchilli, V. ; Costa, L. ; Brady, C. ; Seaman, J. ; Lipton, A.

Oxford: Oxford University Press

Texto completo disponível

P-370 The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer

Almeida, C. ; Goncalves, M. ; Freitas, M. ; Teixeira, C. ; Couto, M. ; Lemos, T. ; Meireles, S. ; Rego, I. ; Sarmento, C. ; Coelho, A. ; Costa, A. ; Barbosa, M.

Elsevier Ltd

Texto completo disponível

Association of ESR1 Polymorphisms with Tamoxifen Response in Women with Estrogen Receptor-Positive Breast Cancer

Almeida, M. ; Portela, C. ; Nabiço, R. ; Ferreira, A. ; Pardal, F. ; Costa, S. ; Ferreira, M. ; Costa, P. ; Viana-Pereira, M. ; Reis, R.

Texto completo disponível

967PSkeletal muscle loss as an adverse event during cabozantinib treatment in patients with metastatic renal cell carcinoma

Alves Costa Silva, C ; Afonso, D ; Colomba, E ; Le Teuff, G ; Derosa, L ; Raynard, B ; Guida, A ; Benchimol-Zouari, A ; Escudier, B ; Bidault, F ; Albiges, L

Oxford University Press

Texto completo disponível

Skeletal muscle loss as an adverse event during cabozantinib treatment in patients with metastatic renal cell carcinoma

Alves Costa Silva, C. ; Afonso, D. ; Colomba, E. ; Le Teuff, G. ; Derosa, L. ; Raynard, B. ; Guida, A. ; Benchimol-Zouari, A. ; Escudier, B. ; Bidault, F. ; Albiges, L.

Texto completo disponível

967P - Skeletal muscle loss as an adverse event during cabozantinib treatment in patients with metastatic renal cell carcinoma

Alves Costa Silva, C. ; Afonso, D. ; Colomba, E. ; Le Teuff, G. ; Derosa, L. ; Raynard, B. ; Guida, A. ; Benchimol-Zouari, A. ; Escudier, B. ; Bidault, F. ; Albiges, L.

Elsevier Ltd

Texto completo disponível

697P Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N)

Alves Costa Silva, C. ; Derosa, L. ; Dalban, C. ; Colomba, E. ; Negrier, S. ; Chevreau, C.M. ; Gravis, G. ; Oudard, S.M. ; Laguerre, B. ; Barthelemy, P. ; Borchiellini, D. ; Gross-Goupil, M. ; Geoffrois, L. ; Rolland, F. ; Thiery-Vuillemin, A. ; Joly, F. ; Ladoire, S. ; Tantot, F. ; Escudier, B. ; Albiges, L.

Elsevier Ltd

Texto completo disponível